CDIO Cardio Diagnostics Holdings Inc. - Common stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 15, 2026CDIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CDIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| May 13, 2025 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CDIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.7 | · | 0.9 | Undervalued |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CDIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 15.8 | · | 7.4 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2025 | $-0.97 | $-1.84 | 47.2% | |
| Dec. 31, 2024 | $-0.30 | $-1.84 | 83.7% | |
| Sept. 30, 2024 | $-1.80 | $-3.06 | 41.2% | |
| June 30, 2024 | $-1.80 | $-3.37 | 46.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $2.7K | $940 | |
| R&D Expense | $129.8K | $118.8K | |
| SG&A Expense | $1M | $1M | |
| Operating Expenses | $2M | $2M | |
| Operating Income | $-2M | $-2M | |
| Interest Expense | $3.4K | $4.7K | |
| Interest Income | $118 | $187 | |
| Other Non-op | $-3.3K | $-4.5K | |
| Pretax Income | $-2M | $-2M | |
| Net Income | $-2M | $-2M | |
| EPS (Basic) | $-0.63 | $-0.97 | |
| EPS (Diluted) | $-0.63 | $-0.97 | |
| Shares (Basic) | 2,840,778 | 1,686,144 | |
| Shares (Diluted) | 2,840,778 | 1,686,144 | |
| EBITDA | $-2M | · |
Balance Sheet
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $0 | · | |
| Receivables | $4.3K | · | |
| Prepaid Expense | $663.3K | · | |
| Current Assets | $8M | · | |
| PP&E (Net) | $657.6K | · | |
| Accum. Depreciation | $321.9K | · | |
| Total Assets | $10M | · | |
| Accounts Payable | $123.0K | · | |
| Current Liabilities | $491.4K | · | |
| Capital Leases | $164.5K | · | |
| Total Liabilities | $656.0K | · | |
| Common Stock | $29 | · | |
| Paid-in Capital | $40M | · | |
| Retained Earnings | $-31M | · | |
| Stockholders' Equity | $9M | · | |
| Liabilities + Equity | $10M | · | |
| Shares Outstanding | 2,959,469 | · |
Cash Flow
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $5.5K | $45.4K | |
| Stock-based Comp | $24.7K | $30.6K | |
| Operating Cash Flow | $-2M | $-1M | |
| CapEx | $1.8K | $5.8K | |
| Investing Cash Flow | $-63.7K | $-47.4K | |
| Financing Cash Flow | $4M | $3M | |
| Free Cash Flow | $-2M | · |
Profitability
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -66598.4% | · | |
| Net Margin | -66722.3% | · | |
| Pretax Margin | -66722.3% | · | |
| EBITDA Margin | -66598.4% | · | |
| ROA | -16.4% | · | |
| ROE | -17.6% | · |
Liquidity & Solvency
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 15.8 | · | |
| Quick Ratio | 0.0 | · | |
| Interest Coverage | -519.0 | · |
Efficiency
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 0.4 | · |
Per Share
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Book Value / Share | $3.01 | · | |
| Revenue / Share | $0.00 | · | |
| Cash Flow / Share | $-0.55 | · | |
| Cash / Share | $0.00 | · | |
| EPS (TTM) | $-3.37 | · |
Valuation (TTM)
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $16.6K | · | |
| Net Income TTM | $-7M | · | |
| Market Cap | $6M | · | |
| P/E | -0.6 | · | |
| P/S | 348.4 | · | |
| P/B | 0.6 | · | |
| P / Tangible Book | 0.6 | · | |
| P / Cash Flow | -3.7 | · | |
| Earnings Yield | -172.8% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 18 filers · $488K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-2 vs prior Q) | 3 (-1 vs prior Q) | 1 (-2 vs prior Q) | 5 (+2 vs prior Q) | -83K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $107,748 | 49,200 | 22.07% | Shares |
| BlackRock, Inc. | $76,011 | 34,708 | 15.57% | Shares |
| VANGUARD GROUP INC | $65,376 | 24,124 | 13.39% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $57,449 | 26,233 | 11.77% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $44,139 | 20,155 | 9.04% | Shares |
| CITADEL ADVISORS LLC | $41,765 | 19,071 | 8.56% | Shares |
| XTX Topco Ltd | $35,244 | 16,093 | 7.22% | Shares |
| JANE STREET GROUP, LLC | $26,133 | 11,933 | 5.35% | Shares |
| STATE STREET CORP | $22,117 | 10,099 | 4.53% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $6,185 | 2,824 | 1.27% | Shares |
| Tower Research Capital LLC (TRC) | $3,962 | 1,809 | 0.81% | Shares |
| UBS Group AG | $1,437 | 656 | 0.29% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $228 | 104 | 0.05% | Shares |
| MORGAN STANLEY | $219 | 100 | 0.04% | Shares |
| OSAIC HOLDINGS, INC. | $35 | 16 | 0.01% | Shares |
| SHP Wealth Management | $35 | 16 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $22 | 10 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $4 | 2 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Robert Philibert, BD Holding, Inc. ×2 filings | June 28, 2023 | · | Initial filing | · | SEC |
| Meeshanthini Dogan, Timur Dogan ×2 filings | June 28, 2023 | · | Initial filing | · | SEC |
| Mana Capital LLC | Dec. 3, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 14 insiders · 5 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Meeshanthini Dogan | Chief Executive Officer | Sept. 6, 2024 P | 1,655,429 | 0 | 0 | $0 |
| Elisa V Luqman | Chief Financial Officer | Jan. 23, 2024 A | · | 0 | 0 | $0 |
| Timur Dogan | Chief Technology Officer | Sept. 6, 2024 P | 197,310 | 0 | 0 | $0 |
| Robert Philibert | Chief Medical Officer | Sept. 6, 2024 P | 1,683,867 | 0 | 0 | $0 |
| Khullani Abdullahi | VP of Revenue and Strategy | Jan. 23, 2024 A | · | 0 | 0 | $0 |
| Peter K Fung | Director | March 31, 2026 A | · | 0 | 0 | $0 |
| Wendy J Betts | Director | March 31, 2026 A | · | 0 | 0 | $0 |
| Paul Frederick Burton | Director | March 31, 2026 A | 8,803 | 0 | 0 | $0 |
| James Intrater | Director | March 31, 2026 A | 71,596 | 0 | 0 | $0 |
| Stanley K. Lau | Director | Sept. 30, 2024 A | 100,325 | 0 | 0 | $0 |
| Oded Levy | Director | Sept. 30, 2024 A | 71,596 | 0 | 0 | $0 |
| Warren Hosseinion | Director | Jan. 23, 2024 A | · | 0 | 0 | $0 |
| Brandon Sim | Director | Dec. 31, 2023 M | 62,793 | 0 | 0 | $0 |
| Mana Capital LLC | 10% owner | Oct. 25, 2022 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 20,155 SH | Aug. 19, 2026 | Daily |
CDIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.